Search results
Maze lands new partner for Pompe drug, after Sanofi pact came apart
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: Biotechnology startup Maze Therapeutics has licensed a Pompe disease drug to Shionogi,...
Vermont Senator Peter Welch criticizes growing profits for pharmaceutical companies outlined in new...
WAMC Northeast Public Radio· 2 days agoFollowing a report issued Tuesday showing record profits from drug companies, Vermont Senator Peter Welch and Michigan Congresswoman Debbie Dingell, both Democrats, are calling ...
Prediction: These 2 Growth Stocks Could Triple By 2030
Motley Fool via Yahoo Finance· 7 hours agoHowever, Axsome's innovative days aren't behind it, which may allow the company to continue...
New Jersey drug company to provide cash, naloxone to Delaware in latest opioid settlement
Delaware Online | The News Journal via Yahoo News· 5 days agoNew Jersey-based drug manufacturer Amneal Pharmaceuticals has become the latest company to reach a settlement agreement with Delaware and other states for ...
Mark Cuban's drug company teams up with platform to bring patients pricing info
Becker’s Hospital Review· 5 days agoThe two announced a new partnership May 7 in which RxLink's MedMap platform, which delivers lowest-cost recommendations for prescribed medications based on a patient's insurance, third-party ...
Pfizer to Settle 10K Lawsuits Over Drug Linked to Cancer, Costing Company Millions
IJR· 2 days agoBig Pharma giant Pfizer confirmed on Wednesday that it will settle more than 10,000 lawsuits over...
Zydus gets final nod from USFDA to market generic arthritis drug
Investing.com· 15 hours agoZydus gets final nod from USFDA to market generic arthritis drug
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
Reuters via Yahoo Finance· 1 day agoHYDERABAD/BENGALURU (Reuters) -Cipla is open to partnering with U.S. drugmaker Eli Lilly to market its blockbuster obesity treatment drugs in India, the company's CEO said ...
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks· 6 days agoPer the Zacks classification, the pharma/biotech industry comes under the broader Medical sector, which comprises pharma/biotech...
Catalyst's New CEO Has Big Ideas For The Small Biotech
Investor's Business Daily· 1 day agoIn an interview with Investor's Business Daily, Daly recalled how...over the past nine years from...